[1] ITO K. Prostate cancer in Asian men[J]. Nature reviews urology,2014,11(4):197.
[2]SIEGEL R L,MILLER K D,JEMAL A. Cancer statistics,2016[J]. Ca a cancer journal for clinicians,2016,66(1):7.
[3]CHOI B M,XIAO Y C,SHANG S G,et al. Anti-apoptotic effect of phloretin on cisplatin-induced apoptosis in HEI-OC1 auditory cells[J]. Pharmacological reports,2011,63(3):708-716.
[4]MIN J,LI X,HUANG K,et al. Phloretin induces apoptosis of non-small cell lung carcinoma A549 cells via JNK1/2 and p38 MAPK pathways[J]. Oncology reports,2015,34(6):2 871-2 879.
[5]KIM M S,KWON J Y,KANG N J,et al. Phloretin induces apoptosis in H-Ras MCF10A human breast tumor cells through the activation of p53 via JNK and p38 mitogen-activated protein kinase signaling[J]. Annals of the New York academy of sciences,2009,1171(1):479-483.
[6]WU C H,HO Y S,TSAI C Y,et al. In vitro and in vivo study of phloretin-induced apoptosis in human liver cancer cells involving inhibition of type Ⅱ glucose transporter[J]. International journal of cancer,2009,124(9):2 210-2 219.
[7]KOBORI M,IWASHITA K,SHINMOTO H,et al. Phloretin-induced apoptosis in B16 melanoma 4A5 cells and HL60 human leukemia cells[J]. Bioscience biotechnology and biochemistry,1999,63(4):719-725.
[8]SZLISZKA E,CZUBA Z P,MAZUR B,et al. Chalcones and dihydrochalcones augment TRAIL-mediated apoptosis in prostate cancer cells[J]. Molecules,2010,15(8):5 336.
[9]ADAMS J M,CORY S. The Bcl-2 protein family:arbiters of cell Survival[J]. Science,1998,281(5 381):1 322-1 326.
[10]冷向锋,程继义. TRAIL与前列腺癌[J]. 国际泌尿系统杂志,2003,23(3):231-233.
[11]TESTA J R,BELLACOSA A. AKT plays a central role in tumorigenesis[J]. Proc Natl Acad Sci USA,2001,98(20):10 983-10 985.
[12]GUANG H X,MICHAEL J,ALFONSO B,et al. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways[J]. Proceedings of the national academy of sciences of the United States of America,2001,98(1):247.
[13]SUN H,KING A J,DIAZ H B,et al. Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase,Cdc42/Rac and Pak[J]. Current biology,2000,10(5):281-284.